@FierceMedDev: Theragenics faced slumping revenue in Q3. The device maker blames hc reform, the device tax and economic uncertainty. More | Follow @FierceMedDev
@MarkHFierce: OraSure's new HIV rapid Dx test helped reduce losses in Q3. News | Follow @MarkHFierce
@DamianFierce: Boston Sci is now a hypertension player, spending $425M on Vessix, a Fierce 15 winner. More | Follow @DamianFierce
> Mako Surgical ($MAKO), a surgical robot maker, boosted revenue and reduced losses in its 2012 third quarter. Story
> Critical Diagnostics says a new study shows its ST2 assay is highly accurate in predicting the risk of heart failure and death in the general population. Item
> Health care supplier Novation submitted comments to the FDA backing a rapid implementation of a unique device identification system for medical devices. Release
> Vision Care won its Health Canada license to market an implantable telescope prosthesis for end-stage macular degeneration. Item
> OraSure Technologies narrowed its quarterly loss by $1.5 million in Q3, predicting a bigger fourth quarter after getting FDA approval for its at-home HIV diagnostic. Article
> A patient was able to climb 103 floors of Chicago's Willis Tower using a neutrally controlled, powered prosthetic limb being developed by Freedom Innovations. Release
> Updated Russian medical device regulations will launch in early 2013, but their implementation remains under question. Item
Biotech News
@FierceBiotech: After cashing in on life-saving boast, biotech stayed mum on patient death. Story | Follow @FierceBiotech
@JohnCFierce: Catalyst $CPRX cocaine addiction drug flops in phase IIb, shares down 65%--a penny stock now. More | Follow @JohnCFierce
@RyanMFierce: GNS Healthcare, Mt. Sinai and Farber want to drop a Big Data bomb on cancer with a computer model of mult. myeloma. Release | Follow @RyanMFierce
> FDA experts give Novartis' Cushing's drug unanimous endorsement. Story
> BioCryst scraps $235M late-stage flu drug program backed by feds. Article
> Novartis R&D spotlights blockbuster hopefuls, promises 14 big approvals. News
Pharma News
@FiercePharma: Will Merck's Oxytrol benefit from new FDA interest in OTC access? More | Follow @FiercePharma
> GSK, XenoPort part ways after Horizant disappointment. Article
> Sun joins dermatology rush with $230M Dusa buyout. News
> Long-term study reinforces safety record of blockbuster Pradaxa. Story
Vaccine News
@AlisonBFierce: The percentage of drug-resistant malaria cases is on the rise in Southeast Asia, a cause for concern among experts. News | Follow @AlisonBFierce
> GSK withdraws infant vaccine in Canada. Article
> BiondVax, MonoSol Rx develop oral universal flu vaccine. News
> Scripps researchers develop methamphetamine vaccine. Story
> PsiOxus lands $2.7M for ovarian cancer vaccine trial. Item
Pharma Manufacturing News
> African raids seize 82M doses of counterfeits. Report
> Another online seller of fake Viagra heads for jail. Story
> Hospira slowly ramps up production. Article
> GlaxoSmithKline pulls vaccines after bacteria found in plant. News